Headlands Technologies »

Amylyx Pharmaceuticals shares owned by Headlands Technologies

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $369k 31k 12.08

More positions owned by Headlands Technologies

Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Booking Holdings (BKNG)
Electronic Arts (EA)
Bank of America Corporation (BAC)
Metropcs Communications (TMUS)
Exxon Mobil Corporation (XOM)
Roper Industries (ROP)
Nasdaq Omx (NDAQ)
Ross Stores (ROST)

View all positions for Headlands Technologies

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Commodore Capital
Saturn V Capital Management
First Light Asset Management
Goldman Sachs Group
Henderson Group
Driehaus Capital Management
Geode Capital Management
Almitas Capital
State Street Corporation

View all funds holding Amylyx Pharmaceuticals